Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-23 Sale | 2019-12-27 4:10 pm | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 11,000 | $59.6 | $655,589 | 315,375 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-10-31 4:05 pm | N/A N/A | Taysha Gene Therapies Inc. | TSHA | Audentes Therapeutics Inc. Astellas Pharma Inc. 10% Owner | 0 | $0 | 7,266,342 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:38 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 183,384 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:38 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 223,873 | $0 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:37 pm | N/A 2027-01-01 | Audentes Therapeutics Inc. | BOLD | Smith Julie Director | 53,200 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:36 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 89,695 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:36 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Schuetz Thomas J. Director | 67,891 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:35 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 433,272 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:35 pm | N/A 2025-12-18 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 734,353 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:34 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP, Chief Commercial Officer | 26,919 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:34 pm | N/A 2029-01-03 | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP, Chief Commercial Officer | 87,750 | $0 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:33 pm | N/A 2025-12-26 | Audentes Therapeutics Inc. | BOLD | Morrison Scott W Director | 77,835 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:32 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP, General Counsel | 32,705 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:32 pm | N/A 2029-03-28 | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP, General Counsel | 104,000 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:31 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 315,375 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:31 pm | N/A 2026-08-24 | Audentes Therapeutics Inc. | BOLD | LANGE LOUIS G Director | 53,200 | $0 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:30 pm | N/A 2027-06-12 | Audentes Therapeutics Inc. | BOLD | Jarrett Jennifer Director | 53,200 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:29 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 104,439 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:29 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 320,348 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:27 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 1,500 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:27 pm | N/A 2028-01-01 | Audentes Therapeutics Inc. | BOLD | Goldberg Mark Alan Director | 48,700 | $0 | 0 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:26 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP, Chief Medical Officer | 24,584 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:26 pm | N/A 2029-07-15 | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP, Chief Medical Officer | 90,000 | $0 | 0 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 6,219 | $15.26 | 260,994 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 150,888 | $0 | 260,994 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:19 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 144,669 | $2.7649 | 260,994 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 11,824 | $9.5 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 64,751 | $0.78 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 11,666 | $15.26 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A 2023-09-25 | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 162,538 | $0 | 765,175 (Direct) | View |
| 2019-12-26 Gift | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 12,500 | $0 | 765,175 (Direct) | View |
| 2020-01-08 Exercise | 2020-01-10 6:18 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 74,297 | $2.19 | 765,175 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:05 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 41,321 | $0 | 180,994 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 41,321 | $2.7649 | 180,994 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:05 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 30,139 | $59.37 | 180,994 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP, Chief Commercial Officer | 4,881 | $59.37 | 26,919 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Meltz Mark A SVP, General Counsel | 4,628 | $59.37 | 32,705 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 74,117 | $15.26 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A 2025-11-06 | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 147,344 | $0 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 6,891 | $27.39 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 45,726 | $2.7649 | 399,787 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 97,609 | $59.37 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 5,715 | $9.4988 | 399,787 (Direct) | View |
| 2019-12-12 Exercise | 2019-12-16 6:03 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 14,895 | $24.74 | 399,787 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:02 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Conner Edward R. SVP, Chief Medical Officer | 5,416 | $59.37 | 24,584 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:17 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Soloway Thomas P Executive Vice President, CFO | 505 | $59.21 | 21,314 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:16 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Patterson Matthew R Chief Executive Officer | 1,974 | $59.21 | 283,234 (Direct) | View |
| 2019-12-05 Tax Withholding | 2019-12-09 5:15 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Holles Natalie C. President and COO | 505 | $59.21 | 54,704 (Direct) | View |